• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40G; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40G; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problem Unsealed Device Packaging (1444)
Patient Problems No Consequences Or Impact To Patient (2199); No Patient Involvement (2645)
Event Date 08/11/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Report source, foreign - event occurred in (b)(6).The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Device not returned.
 
Event Description
It was reported that the outer packaging of bone cement was complete, but there was leakage of powder and the inner sterile packaging was opened.Issue noticed before surgery.
 
Event Description
It was reported that the outer packaging of bone cement was complete, but there was leakage of powder and the inner sterile packaging was opened.The issue was noticed before surgery.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following section has been updated : d4, e1, g1-2, g4, h2, h3, h6, h7, h10.H7 - corrective action has been initiated for the reported issue.The device was not returned to the manufacturer.Therefore it could not be analyzed.The pictures received show that the cement powder has leaked from the inner pouch.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.According to available data, the most probable root cause is due to packaging issue (sealing process).Corrective action has been initiated to address reported issue.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 1X40G
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8240411
MDR Text Key132929137
Report Number3006946279-2018-00428
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Remedial Action Modification/Adjustment
Type of Report Initial,Followup
Report Date 07/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/11/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2020
Device Model NumberN/A
Device Catalogue Number3003940001
Device Lot NumberB711BB0706
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received07/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
-
-